Dr. Christopher Charles Ornelas Sr., MD

Dr. Ornelas practices at USC Verdugo Hills Ambulatory Surgery Center in Glendale, California.

Dr. Ornelas' NPI, 1568637239, was assigned on April 24, 2008. Dr. Ornelas graduated from The University of New Mexico School of Medicine in 2008. Dr. Ornelas' California license number on file is A112082.

Dr. Ornelas' primary practice is USC Verdugo Hills Ambulatory Surgery Center, at 1818 Verdugo Blvd Ste B1, Glendale, CA 91208. The practice phone is (213) 740-7922.

Dr. Ornelas' primary practice is USC Verdugo Hills Ambulatory Surgery Center in Glendale, California. Dr. Ornelas is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Ornelas to 3 more hospitals, 1 physician office, 1 group practice or clinic and 1 other site, each named with a free account. Dr. Ornelas' employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ornelas practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Ornelas' primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Ornelas is board certified in physical medicine & rehabilitation by the American Board of Physical Medicine and Rehabilitation. Dmand AI has Dr. Ornelas' licenses on file in 2 states: California and New Mexico.

Dmand AI lists back pain injection, lower back pain, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Ornelas treats.

CMS data shows 5,174 Medicare services from Dr. Ornelas across 18 procedure codes in 2024, for 1,013 Medicare patients. Medicare paid $380,017 for them.

CMS counts 1,013 Medicare patients who saw Dr. Ornelas in 2024. The largest group is 65 to 74, with 441 patients. 75% of them have arthritis, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ornelas' median patient age at 69, with 59% women.

In 2024, Dr. Ornelas wrote 131 Medicare Part D claims for 85 patients. 99% of them were for generic drugs. CMS names the drug for 108 of them, across 3 drugs with 11 or more claims each, at $962 in total drug cost. In 2023, CMS named 159 claims across 4 drugs.

Dr. Ornelas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ornelas as offering telehealth.

Dmand AI links 1 paper to Dr. Ornelas in 2010. Dr. Ornelas' most frequent co-author is Sanjog Sharad Pangarkar, MD.

CMS Open Payments shows 192 general payments to Dr. Ornelas from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Boston Scientific Corporation paid the most, $1,968.

Dr. Ornelas graduated from The University of New Mexico School of Medicine in 2008. Dr. Ornelas is a member of AAPMR.

Dr. Ornelas is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.